Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

William V. Padula, Sonal Parasrampuria, Mariana P Socal, Rena M. Conti, Gerard F. Anderson

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US'. Together they form a unique fingerprint.

Medicine & Life Sciences